The CRISPR-Cas system provides adaptive immunity against mobile genetic elements in prokaryotes, utilising small CRISPR RNAs which direct effector complexes to degrade invading entities. Type III effector complexes were recently demonstrated to synthesise a novel second messenger, cyclic oligoadenylate (cOA), on binding target RNA. cOA in turn binds to and activates a range of downstream effector proteins including ribonucleases (Csm6/Csx1) and transcription factors via a CARF (CRISPR associated Rossman Fold) domain, inducing an antiviral state in the cell that is important for immunity. The mechanism of the "off-switch" that resets the system is not understood. Here, we report the identification of the nuclease that degrades these cOA ring molecules. The "Ring nuclease" is itself a CARF family protein with a metal independent mechanism, which cleaves cOA4 rings to generate linear di-adenylate species and switches off the antiviral state. The identification of Ring nucleases adds an important insight to the CRISPR-Cas system.
Introduction
Cyclic oligoadenylate (cOA, with a ring size of 4 or 6 AMP monomers) has emerged as a key second messenger signalling the presence of invading mobile genetic elements (MGE) in prokaryotes harbouring type III (Csm/Cmr) CRISPR-Cas systems 1, 2 . cOA is synthesised by the PALM/cyclase domain of the Cas10 subunit, which is activated by the binding of target RNA. cOA in turn activates a range of proteins with CARF (CRISPR associated Rossman Fold) domains including HEPN (Higher Eukaryotes and Prokaryotes Nucleotide binding) domain ribonucleases (Csm6/Csx1) and transcription factors [3] [4] [5] , precipitating an antiviral state in infected cells that may enhance viral clearance, result in dormancy, or cell death 6 . The Csm6 and Csx1 ribonucleases play an important role in CRISPR-based immunity in several systems [7] [8] [9] . cOA is therefore a potent signalling molecule that must be tightly controlled if cells are to survive a viral infection. Synthesis of cOA is switched off when type III effectors cleave and release viral RNA targets 1, 10 . However, this will not remove cOA already synthesised, potentially leading to untrammelled ribonuclease activity and cell death. A variety of other cyclic nucleotide signalling molecules, such as di-cAMP, which perform distinct signalling roles in prokaryotes, are degraded by specific phosphodiesterases 11 , but the enzyme specific for cOA has not been identified. Here, we report the identification and characterisation of a family of enzymes that degrade cOA4, providing a mechanism for the deactivation of the antiviral state induced by cOA in cells harbouring a type III CRISPR-Cas system.
Results
To identify the enzyme responsible for the degradation of cOA, we undertook a classical biochemical approach. We selected the crenarchaeal species Sulfolobus solfataricus for this study, as it has long been a model for biochemical studies of the type III CRISPR system. Starting with S. solfataricus (Sso) cell lysate, we noted the presence of an activity that converted radioactively labelled cOA4 into a form (X) that migrated more slowly in denaturing gel electrophoresis ( Figure 1) . We fractionated the cell lysate through three chromatography steps (phenyl-sepharose, size exclusion and heparin) and followed the activity. The final purification step was followed by assay of each fraction and SDS-PAGE analysis (Figure 1d ), revealing that the activity correlated with a single band. This protein was identified by mass spectrometry as Sso2081a member of the CARF domain-containing protein family 12 (Figure S1 ). To confirm that Sso2081 was the nuclease responsible for degradation of cOA 4 , we expressed and purified the recombinant protein in E. coli. The enzyme converted cOA 4 to a slower-migrating species on gel electrophoresis, as seen for the activity from S. solfataricus extracts, in a reaction independent of divalent metal ions, since activity is maximal in the presence of EDTA (Figure 1e ). We noted that the Csx1 nuclease (Sso1389; PDB 2I71) 10 is found close to an uncharacterised CARF domain protein of known structure, Sso1393 ( Figure S1 ) that is homologous to Sso2081 ( Figure S2 ). Pure recombinant Sso1393 also exhibits cOA4 degradation activity, whilst Csx1 does not ( Figure 1e ). In contrast, of the three enzymes, only Csx1 displays cOA4-stimulated ribonuclease activity on a linear RNA substrate (Figure 1f ). Sso2081 and Sso1393 degrade cOA4 with single-turnover rate constants of 0.23 ± 0.01 and 0.024 ± 0.0004 min -1 , respectively (Figure 2a and S3). The ten-fold higher specific activity of Sso2081, combined with its higher expression levels in S. solfataricus 13 , suggest that it is the major cOA4-degrading enzyme in this organism.
Figure 1. Purification and identification of the enzyme that degrades cOA4
A S. solfataricus cell lysate was fractionated by a, phenyl-sepharose, b, size exclusion and c, heparin chromatography. At each stage, fractions were assayed for cOA4 conversion activity using radioactive cOA4, and active fractions generating product X (indicated by shaded boxes) were pooled for the next stage. d, Following the heparin column, each fraction was assayed and analysed by SDS-PAGE. The band corresponding to the peak of activity (arrowed) was excised from the gel and identified by mass spectrometry as Sso2081, a CARF domain protein. e, Purified recombinant Sso2081 and 1393 degrade cOA4, but Csx1 does not. f, Only Csx1 degrades linear RNA in the presence of cOA4.
Figure S1. Genome organisation of the CRISPR-Cas locus of S. solfataricus
The type I-A, III-B and III-D effector complex operons are depicted, along with genes encoding adaptation proteins and the position of the six CRISPR loci (A-F). Genes outlined in blue encode proteins with CARF domains. The structures of three CARF family proteins are shown with CARF domains coloured green, along with the structure of cOA4.
Metal independent ribonucleases and ribozymes, including the Cas6 nuclease family 14 , share a common mechanism: activation of the 2'-hydroxyl of the ribose sugar as the nucleophile that attacks the phosphodiester bond targeted for cleavage, leading to products with a cyclic 2',3'-phosphate and a 5'-hydroxyl moiety 15 . To determine the degradation products of cOA4 treated with Sso2081 and 1393, we analysed radioactively labelled species by thin layer chromatography (TLC) ( Figure 2b ). Sso2081 converted cOA4 into a faster-migrating form (X) that could be phosphorylated by treatment with polynucleotide kinase (PNK), showing that it was a linear product with a 5'-OH group (lanes 2 and 3). For Sso1393 an intermediate product (Y) with a 5'-OH group that converted over time into the final product (X) was also observed (lanes 4-7). Lanes 8 and 9 show standards generated by cleavage of RNA oligonucleotides by the MazF ribonuclease 10 to generate the species P-OA2>P (5'-phospho-ApAp with a cyclic 2',3' phosphate) and P-OA4>P, respectively. The final products of Sso2081 and 1393 run at the same position as the P-OA2>P standard once phosphorylated by PNK, whilst the intermediate observed for Sso1393 runs at the same position as the P-A4>P standard. To identify products X and Y, we incubated Sso2081 and 1393 individually with cOA4 and analysed the reaction products by liquid chromatography-high resolution mass spectrometry (LC-HRMS, Figure 2c and d). Upon 60 min incubation with recombinant Sso2081, the peak corresponding to cOA4 had almost completely disappeared in favour of the main product (X) with a retention time of 4.4 min alongside a trace of compound Y eluting at 11.9 min (Figure 2c and S4). Linear OA2 and OA4 species with a 2',3'-cyclic phosphate, generated using the MazF toxin 10 , eluted with comparable retention times as products X and Y, respectively. Mass spectrometry revealed product X to have a neutral mass of 658.104 amu, consistent with linear A2>P (expected for C20H24N10O12P2 658.105 amu, m -1.6 ppm). The mass of product Y (1316.208 amu), on the other hand, was consistent with A4>P (expected for C40H48N20O24P4 1316.210 amu, m -1.6 ppm). The same products were observed for Sso1393 (Figure 2d and S4). Again, compound X was the main product with the peak corresponding to compound Y more visible at early time points compared to the Sso2081 reaction. The occurrence of one major product X for both enzymatic reactions and the detection of an apparent intermediate Y for the Sso1393 reaction are both in agreement with observations from TLC analysis, which demonstrates that product Y is only ever observed in very small amounts in the Sso2081 reaction, probably due to the significantly faster catalytic rate of this enzyme ( Figure S5 ). Thus, these enzymes break the cOA4 ring using a metal-independent mechanism, generating linear A4>P intermediate and A2>P products with 5'-OH and 2',3'-cyclic phosphate termini. We propose the collective term "Ring nucleases" for this family of phosphodiesterases. Figure S2 . Structure-guided sequence alignment of Sso1393, Sso2081 and orthologues. Multiple sequence alignment showing Sso1393 with three homologues from the Sulfolobales aligned with Sso2081 and 3 homologues. Secondary structure is shown above the alignment, based on the structure of Sso1393 (PDB 3QYF). Ser-11 and Lys-168 are indicated by asterisks. Conserved residues are shaded. Sequences aligned are from S. solfataricus (Sso1393, Sso2081); S. islandicus REY15A (SiRE_0811 SiRE_0455); S. islandicus M.16.4 (M164_0884); S. acidocaldarius (Saci_1063) and S. tokodaii (Stk_17430).
The structure of Sso1393 (PDB 3QYF, unpublished) reveals a canonical CARF domain formed by a homodimeric subunit arrangement, with a C-terminal extension ( Figure S1 ). To help understand the mechanism of Ring nucleases, we docked cOA4 into the CARF domain of Sso1393 (Figure 3a and S6). This is a simple model without any attempt at energy minimisation but allows hypotheses concerning the enzyme mechanism to be drawn. Using structure-guided multiple sequence alignment of Sso1393, Sso2081 and homologues, we identified conserved residues positioned close to the cOA4 binding site that might play a role in catalysis (Figure 3 , S2, S6). We noted the conservation of a lysine (K168 in Sso1393) that is predicted to lie in the centre of the cOA4 binding site and which could thus play a role in catalysis. Sso2081 has two basic residues (R105/K106) in this position. The K168A variant of Sso1393 was catalytically inactive, as was the Sso2081 R105A/K106A variant, confirming an important role in cOA catalysis, possibly by stabilising the pentacovalent phosphorous generated in the transition state 15 (Figure 3b , S6d). The absolutely conserved residue S11 (Figure 3 ), was also targeted by mutagenesis. The S11A variant had a significantly lower catalytic rate constant for both enzymes, with kcat reduced 3.5 and 32-fold for Sso2081 and Sso1393, respectively (Figure 3b , S6). Consistent with the absence of Ring nuclease activity, Csx1 lacks these key active site residues.
Based on the evidence available, we propose that cleavage of cOA4 is catalysed by binding the molecule in an orientation that allows the 2'-hydroxyl of the ribose to attack the bridging phosphorus, coupled with stabilisation of the developing transition state by the basic residue(s) at the base of the binding pocket ( Figure 3c ). The single turnover rate constant for Sso2081, at below 1 min -1 , is comparable to the Cas6 nuclease family, which use a similar mechanism 14, 16 . Given the dimeric organisation of the CARF domain there is the possibility for two active sites acting on opposite sides of the cOA4 ring, consistent with the observation of an OA2>P product. For the slower Sso1393 enzyme, appreciable levels of OA4>P intermediate were observed, suggesting that the two active sites need not function in a concerted manner. The active site residues K168 and S11 are shown. b, Kinetic analysis of Sso1393 (wild-type, S11A and K168A variants) and Sso2081 (wild-type, S11A and R105A/K106A variants). Catalytic rate constants under single turnover conditions are plotted. The data are derived from triplicate rate measurements ( Figure S6d ), and standard errors are shown. c, Cartoon showing the reaction scheme for conversion of cyclic to linear OA4 and OA2. S11 may participate in the correct positioning of the 2'-OH group of the ribose to facilitate nucleophilic attack, whilst the basic residue K168 (and R105/K106 in Sso2081) is essential for catalysis and may stabilise the pentacovalent phosphorus formed in the transition state.
We next wished to reconstitute the cOA signalling system in vitro to confirm the function of the Ring nucleases. We set up a reaction containing the Csm (Type III-D) effector complex, 0.5 mM ATP and a variable concentration of target RNA from 10 to 0.01 nM, to activate cOA4 synthesis. After incubation for 1 h at 70 °C in the presence or absence of Sso2081, the HEPN ribonuclease Csx1 together with radioactively labelled Csx1 substrate RNA were added. Target RNA binding by Csm activates the Cyclase domain, switching on cOA production. The Cyclase domain is deactivated when target RNA is cleaved and dissociates from Csm, leaving the complex free to bind to further targets. Higher target RNA concentrations thus result in higher levels of cOA4 10 and stronger activation of Csx1, which degrades a labelled substrate RNA (Figure 4a ). The presence of Sso2081 abrogated the activation of Csx1 in a target RNA concentration-dependent manner. This recapitulates the situation likely to prevail in cells infected with a virus, where viral RNA load determines the extent of cOA production and speed of subsequent clearance by the Ring nuclease (Figure 4b ). Thus, we have identified a family of CARF-domain containing Ring nucleases as the enzymes responsible for the degradation of cyclic oligoadenylate, which is synthesised by type III CRISPR systems in response to detection of viral RNA. The Ring nucleases can be considered to act as the "off-switch" for the system, limiting the damage caused by the HEPN ribonucleases activated by cOA once invading RNA has been cleared from the cell. Many type III CRISPR-Cas systems have multiple associated CARF-domain containing proteins, some of which may be specialised for the degradation of cOA. In a minimal system, it is possible that a single enzyme has a C-terminal HEPN family ribonuclease coupled to an N-terminal CARF family Ring nuclease. This would allow cOA binding to rapidly switch on the ribonuclease activity and then slowly auto-deactivate by cOA cleavage. However, specialisation of CARF proteins as Ring nucleases would yield the advantage of allowing levels of cOA-activated ribonuclease and cOA-degrading Ring nuclease activity to be controlled independently. It is also possible that cOA6 rings such as those generated in Streptococcus thermophilus will be processed differently, as they are likely to have more conformational flexibility than cOA4. The recent identification of a wide range of as-yet uncharacterised CARF domain proteins across the prokarya 5 suggests that we have only scratched the surface of this system. These are fruitful areas for future studies. in abundance of the m/z 657.1 species. The broad peak at 4.1 -6 min is an unknown contaminant likely resulting from the phenol-chloroform extraction. c, Mass spectra for species X and Y. Calculated for C20H23N10O12P2 -1 (cA2 / A2>P) m/z 657.0978, found 657.0968 (m -1.4 ppm); calculated for C40H46N20O24P4 -2 (cA4 / A4>P) m/z 657.0978, found 657.0967 (m -1.6 ppm). d, Ion chromatograms extracted for m/z 657.1 (cA2 -1 , A2>P -1 , cA4 -2 , A4>P -2 ). Individual lanes are labeled. cOAs (mainly cOA4), derived from reaction of Csm with ATP, was incubated with Sso2081 for 60 and 150 min. Linear oligoadenylates with 2',3'-cyclic phosphate were derived from hydrolysis of A4 RNA oligonucleotide with MazF. e, UV traces at 254 nm. Peaks that change in intensity over the course of the enzymatic reaction are indicated by arrows. The three peaks that decreased or increased over the course of the reaction all match the changes in abundance of the m/z 657.1 species. No changes are observed after 60 min reaction time. The broad peak at 4.9 min is an unknown contaminant likely resulting from the phenol-chloroform extraction. Shifts in retention time are possibly due to matrix effects. f, Mass spectra for cOA4 and product X. Calculated for C20H23N10O12P2 -1 (cA2 / A2>P) m/z 657.0978, found 657.0966 (m -1.8 ppm); calculated for C40H46N20O24P4 -2 (cA4 / A4>P) m/z 657.0978, found 657.0967 (m -1.6 ppm). Figure 3 . The CARF domain is coloured green. The side chains of Ser-11 and Lys-168 are shown. b, Model of the Sso2081 structure. Only the CARF domain (aa1-125) is modelled. Conserved residues Ser-11, Arg-105 and Lys-106 are labelled. Model generated using Phyre 1 . c, Representative phosphorimages of denaturing PAGE assessing the cOA4 degradation activity of Sso2081 compared to its catalytically inactive R105A/K106A mutant over time (left hand panel), and Sso1393 activity compared to its K168A mutant (right hand panel). All reactions were carried out at 70 °C with 2 M protein dimer. d, Single-turnover kinetics of Sso2081 and Sso1393 plotted alongside their S11A active site mutants and fitted to an exponential equation. Rate constants (fraction of cOA4 cleaved per min) are displayed with the legend (Sso2081; 0.23 ± 0.01 min -1 , Sso2081 S11A; 0.066 ± 0.002 min -1 , Sso1393; 0.024 ± 0.0003 min -1 , Sso1393 S11A; 0.00076 ± 0.001 min -1 ). Experiments were carried out in triplicate and error bars show standard deviation.
Cyclic oligoadenosine nuclease assays and kinetic analysis 32 P--ATP incorporated cyclic oligoadenylate was generated using the Csm complex as previously described 10 . Briefly, the Csm complex was incubated for 2 h at 70 ºC in 100 µl final reaction volume in a pH 5.5 buffer containing 20 mM MES, 100 mM potassium glutamate and 1 mM DTT supplemented with 2 mM MgCl2, 1 mM ATP, 3 nM 32 P--ATP and 100 nM A26 target RNA (5'-AGGGUCGUUGUUAAGAACGACGUUGUUAGAAGUUGGGUAUGGUGGAGA). The reaction was stopped by phenol-chloroform extraction followed by chloroform extraction. Sso1393, Sso2081, and their mutants were assayed for labelled cOA4 degradation by incubating 2 M protein dimer with 1/300 diluted Csm generated 32 P labelled cOA (0.33 µl per 100 µl reaction) in buffer G (20 mM 2amino-2-(hydroxymethyl)-1,3-propanediol pH 8.0, 100 mM NaCl, 1 mM EDTA and 1 mM DTT) at 70 °C. At desired time points, a 10 l aliquot was removed, and the reaction quenched by adding to chilled phenol-chloroform (Ambion). Subsequently, 5 l of deproteinised reaction product was extracted into 5 l 100% formamide for denaturing PAGE. Control reactions include cOA incubated in buffer G without protein at 4 °C and at 60 °C up to the endpoint of each experiment (typically 20, 120 or 180 min) phenol-chloroform extracted as above. All experiments were carried out in triplicate. cOA4 degradation was visualised by phosphorimaging following denaturing PAGE (7M Urea, 20% acrylamide, 1x TBE). For kinetic analysis, cOA4 cleavage was quantified using the Bio-Formats plugin 19 of ImageJ 20 as distributed in the Fiji package 21 and fitted to a single exponential curve using Kaleidagraph (Synergy Software), as described previously 22 .
HEPN nuclease deactivation assays
For degradation of cOA4, Csm generated cOA was incubated with 2 M Sso2081 dimer or 4 M Sso1393 dimer in buffer K for 60 min and 120 min, respectively. Subsequently, the reaction was deproteinised by phenol-chloroform extraction and diluted two-fold in RNase free water. As a control reaction, cOA was mock treated in buffer with water in place of protein and deproteinised as before. 500 nM Csx1 was incubated with 50 nM A1 RNA and either no cOA activator, 1/100 diluted untreated Csm cOA, 1/100 mock treated cOA or 1/100 ring nuclease treated cOA in buffer containing 20 mM MES pH 5.5, 100 mM K-glutamate and 1 mM DTT for 60 min at 70 °C. Reactions were quenched by the addition of a reaction volume equivalent of 100% formamide, and RNA cleavage was assessed by phosphorimaging following denaturing PAGE.
Reconstitution of the cOA signalling pathway The Csm complex (70 nM carrying the crRNA targeting A26) was incubated for 1 h at 70 ºC in presence of 2.5 µM of Sso2081 dimer and various concentrations of target A26 ssRNA in a reaction containing 20 mM MES pH 6.0, 100 mM NaCl, 1 mg/ml BSA, 2 mM MgCl2, 0.5 mM ATP and a 5'labeled A1 ssRNA that is not recognised by the Csm complex (5'-AGGGUAUUAUUUGUUUGUUUCUUCUAAACUAUAAGCUAGUUCUGGAGA).
After 1 h incubation, 500 nM of Csx1 dimer was added to the reaction for a further 20 min. Reactions were quenched by deproteination with phenol-chloroform extraction and run on a 20% acrylamide 7 M urea denaturing gel prior to phosphorimaging to visualise A1 RNA cleavage.
Generation of standards using the MazF nuclease
The E. coli toxin-antitoxin MazEF was purified as previously described 10 . Active MazF was liberated by either trypsin (Promega) digestion (1600:1) at 37 °C for 15 min or by incubation with Factor X (0.1 unit per 1 mg of protein; Sigma-Aldrich) activated in FXa buffer containing 10 mM Tris-HCl pH 8.0 and 1 mM DTT. For generating linear oligoadenylates A2>P (5' hydroxyl-Ap-Ap with cyclic 2',3' phosphate) and A4>P, 30 M A2 (AAACAUCAG) or A4 (AAAAACAUCAG) MazF RNA was incubated with MazF in FXa buffer for 1 h at 37 °C. RNA was deproteinised by phenol-chloroform extraction followed by chloroform extraction. For use as standards, A2>P and A4>P linear oligoadenylates were 5'-end labelled using 32 P--ATP and T4 Polynucleotide Kinase (PNK; Thermo Fisher Scientific) via its forward reaction.
Thin-layer chromatography
Experiments were performed using silica gel on a 20 x 20 cm TLC plate (Supelco Sigma-Aldrich) containing a fluorescent indicator, allowing visualisation of non-radioactive products by UV shadowing. Prior to loading, all samples were deproteinised by phenol-chloroform followed by
